CLEARPOINT NEURO, INC. COMMON STOCK CLPT 深 滬
等待開盤 10-06 09:30:00 美东时间
27.38
+2.330
+9.30%
華盛通- 最 高28.80
- 今 開27.06
- 成交量 250.62万股
- 最 低 26.60
- 昨 收 25.05
- 總市值 7.74亿
- 52周最高 28.80
- 市盈率 靜 --
- 換手率 8.87%
- 52周最低 9.76
- 委 比 52.78%
- 總股本 2826.50万
- 歷史最高 31.29
- 量 比 1.81
- 振 幅 8.78%
- 歷史最低 2.86
- 每 手 1
- 風險率 2.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ClearPoint Neuro Unveils Robotic Neuro-Navigation System To Advance Cell And Gene Therapy Procedures
New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene TherapySOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the
10-02 04:10
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket
Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritten public offering of common stock and pre-funded warrants.
09-25 18:11
美股牛股 | 特朗普政府拟购10%股权！锂矿股Lithium上演翻倍行情；创新药公司uniQure单日暴涨247%
特朗普政府拟购10%股权！锂矿股Lithium股价上演翻倍行情；创新药公司uniQure单日暴涨247%，核心在研药获关键进展，拟增发募资2亿美元>>
09-25 16:47
ClearPoint Neuro Secures FDA Clearance For 1.5T MRI Use, Expanding Reach For Prism Neuro Laser System
ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that the ClearPoint Prism® Neuro
09-05 04:10
ClearPoint Neuro Reports Record Q2 Revenue Growth
An update from ClearPoint Neuro ( ($CLPT) ) is now available. On August 12, 202...
08-13 04:49
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: CoreWeave (CRWV) Inovio Pharmaceuticals (INO) Luminar Technologies (LAZR) Lumentum Holdings (LITE) Gladstone Investment Corporation (GAIN) Ot...
08-12 22:00
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9
Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $8 to $9.
08-01 22:45
ClearPoint Neuro Updates Director Compensation Plan
The latest announcement is out from ClearPoint Neuro ( ($CLPT) ). ClearPoint Ne...
05-20 05:16
